{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:14:06Z","timestamp":1781734446467,"version":"3.54.5"},"reference-count":59,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation, China","doi-asserted-by":"publisher","award":["ZR2020QC075"],"award-info":[{"award-number":["ZR2020QC075"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Anaplastic Thyroid Cancer (ATC) is a rare subtype of thyroid tumors with a high mortality\nrate. Targeted therapies against ATC are ineffective and mostly transient. Artemisinin has shown excellent anti-tumor\nactivity in several cancers, but its effects on ATC are still unknown.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To evaluate the effects of artemisinin on ATC cells and assess the mechanism underlying drug resistance.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The viability and proliferation rates of the artemisinin-treated CAL-62 and BHT-101 cells were analyzed by\nMTT and EdU incorporation assays. The protein expression levels were determined by Tandem Mass Tag (TMT)\nlabeling quantitative proteomics and western blotting.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Artemisinin treatment significantly decreased the expression levels of COX2 and COX7A2 and increased that\nof COX14, YEM1l1, ALAS1, and OAT after 48h. In addition, FTL was upregulated in the CAL-62 cells and downregulated\nin BHT-101 cells. The CAL-62 cells showed transient and reversible resistance to artemisinin, which was\ncorrelated to time-dependent changes in HIF1\u03b1, PDK1, and PDHA levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Artemisinin targets the mitochondrial respiratory chain proteins in ATC cells. CAL-62 cells show transient\nresistance to artemisinin via PDH downregulation, indicating that PDH activation may enhance the cytotoxic\neffects of artemisinin on ATC cells<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520621666210910100803","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T09:20:13Z","timestamp":1631524813000},"page":"1753-1760","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inactivation of PDH can Reduce Anaplastic Thyroid Cancer Cells\u2019 Sensitivity to Artemisinin"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-1079","authenticated-orcid":true,"given":"Yitian","family":"Li","sequence":"first","affiliation":[{"name":"Research Department of Jining Medical University, Jining, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"Siegel R.L.","year":"2020","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2020. CA Cancer J Clin 2020,70(1),7-30","journal-title":"CA Cancer J Clin"},{"key":"ref=2","author":"Limaiem F.","year":"2020","unstructured":"Limaiem F.; Kashyap S.; Giwa A.O.;  2020"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"Cabanillas M.E.","year":"2016","unstructured":"Cabanillas M.E.; McFadden D.G.; Durante C.; Thyroid cancer. Lancet 2016,388(10061),2783-2795","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2020.01.005","volume":"61","author":"Pozdeyev N.","year":"2020","unstructured":"Pozdeyev N.; Rose M.M.; Bowles D.W.; Schweppe R.E.; Molecular therapeutics for anaplastic thyroid cancer. Semin Cancer Biol 2020,61,23-29","journal-title":"Semin Cancer Biol"},{"key":"ref=5","first-page":"974","volume":"12","author":"Ma M.","year":"2020","unstructured":"Ma M.; Lin B.; Wang M.; Liang X.; Su L.; Okose O.; Lv W.; Li J.; Immunotherapy in anaplastic thyroid cancer. Am J Transl Res 2020,12(3),974-988","journal-title":"Am J Transl Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3892\/ijo.18.4.767","volume":"18","author":"Efferth T.","year":"2001","unstructured":"Efferth T.; Dunstan H.; Sauerbrey A.; Miyachi H.; Chitambar C.R.; The anti-malarial artesunate is also active against cancer. Int J Oncol 2001,18(4),767-773","journal-title":"Int J Oncol"},{"key":"ref=7","author":"Woerdenbag H.J.","unstructured":"Woerdenbag H.J.; Moskal T.A.; Pras N.; Malingr\u00e9 T.M.;"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/np50096a007","volume":"56","author":"El-Feraly F.S.","year":"1993","unstructured":"El-Feraly F.S.; Kampinga H.H.; Konings A.W.; Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod 1993,56(6),849-856","journal-title":"J Nat Prod"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","volume":"91","author":"Lai H.","year":"1995","unstructured":"Lai H.; Singh N.P.; Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 1995,91(1),41-46","journal-title":"Cancer Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","volume":"37","author":"Efferth T.","year":"2004","unstructured":"Efferth T.; Benakis A.; Romero M.R.; Tomicic M.; Rauh R.; Steinbach D.; H\u00e4fer R.; Stamminger T.; Oesch F.; Kaina B.; Marschall M.; Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 2004,37(7),998-1009","journal-title":"Free Radic Biol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1517\/14728222.9.5.995","volume":"9","author":"Lai H.","year":"2005","unstructured":"Lai H.; Sasaki T.; Singh N.P.; Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Expert Opin Ther Targets 2005,9(5),995-1007","journal-title":"Expert Opin Ther Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1211\/jpp.59.6.0011","volume":"59","author":"Huang X.J.","year":"2007","unstructured":"Huang X.J.; Ma Z.Q.; Zhang W.P.; Lu Y.B.; Wei E.Q.; Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. J Pharm Pharmacol 2007,59(6),849-856","journal-title":"J Pharm Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"E1331","DOI":"10.3390\/molecules21101331","volume":"21","author":"Li Z.","year":"2016","unstructured":"Li Z.; Li Q.; Wu J.; Wang M.; Yu J.; Artemisinin and its derivatives as a repurposing anticancer agent: What else do we need to do? Molecules 2016,21(10),E1331","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"247597","DOI":"10.1155\/2012\/247597","volume":"2012","author":"Crespo-Ortiz M.P.","year":"2012","unstructured":"Crespo-Ortiz M.P.; Wei M.Q.; Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol 2012,2012,247597","journal-title":"J Biomed Biotechnol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1124\/mol.64.2.382","volume":"64","author":"Efferth T.","year":"2003","unstructured":"Efferth T.; Sauerbrey A.; Olbrich A.; Gebhart E.; Rauch P.; Weber H.O.; Hengstler J.G.; Halatsch M.E.; Volm M.; Tew K.D.; Ross D.D.; Funk J.O.; Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 2003,64(2),382-394","journal-title":"Mol Pharmacol"},{"key":"ref=15","first-page":"216","volume":"1846","author":"Icard P.","year":"2014","unstructured":"Icard P.; Kafara P.; Steyaert J.M.; Schwartz L.; Lincet H.; The metabolic cooperation between cells in solid cancer tumors. Biochim Biophys Acta 2014,1846(1),216-225","journal-title":"Biochim Biophys Acta"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbabio.2010.09.003","volume":"1807","author":"Solaini G.","year":"2011","unstructured":"Solaini G.; Sgarbi G.; Baracca A.; Oxidative phosphorylation in cancer cells. Biochim Biophys Acta 2011,1807(6),534-542","journal-title":"Biochim Biophys Acta"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biocel.2012.04.024","volume":"45","author":"Villalba M.","year":"2013","unstructured":"Villalba M.; Rathore M.G.; Lopez-Royuela N.; Krzywinska E.; Garaude J.; Allende-Vega N.; From tumor cell metabolism to tumor immune escape. Int J Biochem Cell Biol 2013,45(1),106-113","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1158\/1078-0432.CCR-04-2626","volume":"11","author":"Kelloff G.J.","year":"2005","unstructured":"Kelloff G.J.; Hoffman J.M.; Johnson B.; Scher H.I.; Siegel B.A.; Cheng E.Y.; Cheson B.D.; O\u2019shaughnessy J.; Guyton K.Z.; Mankoff D.A.; Shankar L.; Larson S.M.; Sigman C.C.; Schilsky R.L.; Sullivan D.C.; Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005,11(8),2785-2808","journal-title":"Clin Cancer Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"Bhattacharya B.","year":"2016","unstructured":"Bhattacharya B.; Mohd Omar M.F.; Soong R.; The Warburg effect and drug resistance. Br J Pharmacol 2016,173(6),970-979","journal-title":"Br J Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"Denko N.C.","year":"2008","unstructured":"Denko N.C.; Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008,8(9),705-713","journal-title":"Nat Rev Cancer"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","volume":"14","author":"Nogueira V.","year":"2008","unstructured":"Nogueira V.; Park Y.; Chen C.C.; Xu P.Z.; Chen M.L.; Tonic I.; Unterman T.; Hay N.; Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008,14(6),458-470","journal-title":"Cancer Cell"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1530\/ERC-14-0299","volume":"21","author":"Baldini E.","year":"2014","unstructured":"Baldini E.; Tuccilli C.; Prinzi N.; Sorrenti S.; Antonelli A.; Gnessi L.; Morrone S.; Moretti C.; Bononi M.; Arlot-Bonnemains Y.; D\u2019Armiento M.; Ulisse S.; Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines. Endocr Relat Cancer 2014,21(5),797-811","journal-title":"Endocr Relat Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"E1030","DOI":"10.3390\/ijms19041030","volume":"19","author":"Li Y.T.","year":"2018","unstructured":"Li Y.T.; Tian X.T.; Wu M.L.; Zheng X.; Kong Q.Y.; Cheng X.X.; Zhu G.W.; Liu J.; Li H.; Resveratrol suppresses the growth and enhances retinoic acid sensitivity of anaplastic thyroid cancer cells. Int J Mol Sci 2018,19(4),E1030","journal-title":"Int J Mol Sci"},{"key":"ref=24","first-page":"499","volume":"44","author":"Krishnamurthy S.","year":"2003","unstructured":"Krishnamurthy S.; Cerulli-Switzer J.; Chapman N.; Krishnamurthy G.T.; Comparison of gallbladder function obtained with regular CCK-8 and pharmacy-compounded CCK-8. J Nucl Med 2003,44(4),499-504","journal-title":"J Nucl Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10103-011-1005-z","volume":"27","author":"Peng F.","year":"2012","unstructured":"Peng F.; Wu H.; Zheng Y.; Xu X.; Yu J.; The effect of noncoherent red light irradiation on proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells. Lasers Med Sci 2012,27(3),645-653","journal-title":"Lasers Med Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1038\/s41598-018-28948-z","volume":"8","author":"Klopfenstein D.V.","year":"2018","unstructured":"Klopfenstein D.V.; Zhang L.; Pedersen B.S.; Ram\u00edrez F.; Warwick Vesztrocy A.; Naldi A.; Mungall C.J.; Yunes J.M.; Botvinnik O.; Weigel M.; Dampier W.; Dessimoz C.; Flick P.; Tang H.; GOATOOLS: A python library for gene ontology analyses. Sci Rep 2018,8(1),10872","journal-title":"Sci Rep"},{"key":"ref=27","first-page":"W316-22","volume":"39","author":"Xie C.","year":"2011","unstructured":"Xie C.; Mao X.; Huang J.; Ding Y.; Wu J.; Dong S.; Kong L.; Gao G.; Li C.Y.; Wei L.; KOBAS 2.0: A web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 2011,39,W316-22","journal-title":"Nucleic Acids Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrm3305","volume":"13","author":"Wellen K.E.","year":"2012","unstructured":"Wellen K.E.; Thompson C.B.; A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 2012,13(4),270-276","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1126\/science.3103217","volume":"235","author":"Flier J.S.","year":"1987","unstructured":"Flier J.S.; Mueckler M.M.; Usher P.; Lodish H.F.; Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Sci 1987,235(4795),1492-1495","journal-title":"Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1126\/science.3029870","volume":"235","author":"Birnbaum M.J.","year":"1987","unstructured":"Birnbaum M.J.; Haspel H.C.; Rosen O.M.; Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Sci 1987,235(4795),1495-1498","journal-title":"Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"Carracedo A.","year":"2013","unstructured":"Carracedo A.; Cantley L.C.; Pandolfi P.P.; Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 2013,13(4),227-232","journal-title":"Nat Rev Cancer"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"Birsoy K.","year":"2015","unstructured":"Birsoy K.; Wang T.; Chen W.W.; Freinkman E.; Abu-Remaileh M.; Sabatini D.M.; An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 2015,162(3),540-551","journal-title":"Cell"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","volume":"28","author":"Flaveny C.A.","year":"2015","unstructured":"Flaveny C.A.; Griffett K.; El-Gendy, Bel-D.; Kazantzis, M.; Sengupta, M.; Amelio, A.L.; Chatterjee, A.; Walker, J.; Solt, L.A.; Kamenecka, T.M.; Burris, T.P. Broad anti-tumor activity of a small molecule that selectively targets the warburg effect and lipogenesis. Cancer Cell 2015,28(1),42-56","journal-title":"Cancer Cell"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"Sullivan L.B.","year":"2015","unstructured":"Sullivan L.B.; Gui D.Y.; Hosios A.M.; Bush L.N.; Freinkman E.; Vander Heiden M.G.; Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 2015,162(3),552-563","journal-title":"Cell"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.12.025","volume":"104","author":"Qiu H.Y.","year":"2016","unstructured":"Qiu H.Y.; Wang P.F.; Li Z.; Ma J.T.; Wang X.M.; Yang Y.H.; Zhu H.L.; Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. Pharmacol Res 2016,104,86-96","journal-title":"Pharmacol Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cellsig.2015.01.014","volume":"27","author":"Li F.","year":"2015","unstructured":"Li F.; Zhu Y.T.; HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1\/2-COX-2 signaling. Cell Signal 2015,27(4),860-866","journal-title":"Cell Signal"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1002\/jcp.27411","volume":"234","author":"Hashemi Goradel N.","year":"2019","unstructured":"Hashemi Goradel N.; Najafi M.; Salehi E.; Farhood B.; Mortezaee K.; Cyclooxygenase-2 in cancer: A review. J Cell Physiol 2019,234(5),5683-5699","journal-title":"J Cell Physiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1074\/jbc.M109284200","volume":"277","author":"You K.R.","year":"2002","unstructured":"You K.R.; Wen J.; Lee S.T.; Kim D.G.; Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl)retinamise-induced oxidative stress in hepatoma cells. J Biol Chem 2002,277(6),3870-3877","journal-title":"J Biol Chem"},{"key":"ref=39","first-page":"1309","volume":"42","author":"Slapke J.","year":"1983","unstructured":"Slapke J.; Schewe T.; Hummel S.; Winkler J.; Kopf M.; Lung strips from guinea pigs as test system for lipoxygenase inhibitors. Inhibition of arachidonic acid-induced contractions by 3-t-butyl-4-hydroxyanisole and nordihydroguaiaretic acid. Biomed Biochim Acta 1983,42(10),1309-1318","journal-title":"Biomed Biochim Acta"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10863-006-9064-8","volume":"39","author":"Hilf R.","year":"2007","unstructured":"Hilf R.; Mitochondria are targets of photodynamic therapy. J Bioenerg Biomembr 2007,39(1),85-89","journal-title":"J Bioenerg Biomembr"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1016\/j.bmcl.2008.08.100","volume":"18","author":"Biasutto L.","year":"2008","unstructured":"Biasutto L.; Mattarei A.; Marotta E.; Bradaschia A.; Sassi N.; Garbisa S.; Zoratti M.; Paradisi C.; Development of mitochondria-targeted derivatives of resveratrol. Bioorg Med Chem Lett 2008,18(20),5594-5597","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1021\/mp0500667","volume":"3","author":"Asayama S.","year":"2006","unstructured":"Asayama S.; Kawamura E.; Nagaoka S.; Kawakami H.; Design of manganese porphyrin modified with mitochondrial signal peptide for a new antioxidant. Mol Pharm 2006,3(4),468-470","journal-title":"Mol Pharm"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/mp800019g","volume":"5","author":"Cuchelkar V.","year":"2008","unstructured":"Cuchelkar V.; Kopeckov\u00e1 P.; Kopecek J.; Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting. Mol Pharm 2008,5(5),776-786","journal-title":"Mol Pharm"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.celrep.2016.02.011","volume":"14","author":"Rainbolt T.K.","year":"2016","unstructured":"Rainbolt T.K.; Lebeau J.; Puchades C.; Wiseman R.L.; Reciprocal Degradation of YME1L and OMA1 Adapts Mitochondrial Proteolytic Activity during Stress. Cell Rep 2016,14(9),2041-2049","journal-title":"Cell Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1038\/ncomms13301","volume":"7","author":"Shi H.","year":"2016","unstructured":"Shi H.; Rampello A.J.; Glynn S.E.; Engineered A.A.A.; Engineered AAA+ proteases reveal principles of proteolysis at the mitochondrial inner membrane. Nat Commun 2016,7,13301","journal-title":"Nat Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1042\/BC20070110","volume":"100","author":"Guillery O.","year":"2008","unstructured":"Guillery O.; Malka F.; Landes T.; Guillou E.; Blackstone C.; Lomb\u00e8s A.; Belenguer P.; Arnoult D.; Rojo M.; Metalloprotease-mediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell 2008,100(5),315-325","journal-title":"Biol Cell"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7554\/eLife.16078","volume":"5","author":"Hartmann B.","year":"2016","unstructured":"Hartmann B.; Wai T.; Hu H.; MacVicar T.; Musante L.; Fischer-Zirnsak B.; Stenzel W.; Gr\u00e4f R.; van den Heuvel L.; Ropers H.H.; Wienker T.F.; H\u00fcbner C.; Langer T.; Kaindl A.M.; Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation. eLife 2016,5,5","journal-title":"eLife"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13073-017-0420-6","volume":"9","author":"Srinivasainagendra V.","year":"2017","unstructured":"Srinivasainagendra V.; Sandel M.W.; Singh B.; Sundaresan A.; Mooga V.P.; Bajpai P.; Tiwari H.K.; Singh K.K.; Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma. Genome Med 2017,9(1),31","journal-title":"Genome Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/S0021-9258(18)93310-7","volume":"243","author":"Herzfeld A.","year":"1968","unstructured":"Herzfeld A.; Knox W.E.; The properties, developmental formation, and estrogen induction of ornithine aminotransferase in rat tissues. J Biol Chem 1968,243(12),3327-3332","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/S0021-9258(19)78217-9","volume":"244","author":"Peraino C.","year":"1969","unstructured":"Peraino C.; Bunville L.G.; Tahmisian T.N.; Chemical, physical, and morphological properties of ornithine Aminotransferase from rat liver. J Biol Chem 1969,244(9),2241-2249","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4615-5945-0_8","volume":"420","author":"Seiler N.","year":"1997","unstructured":"Seiler N.; Ornithine aminotransferase as a therapeutic target in hyperammonemias. Adv Exp Med Biol 1997,420,113-142","journal-title":"Adv Exp Med Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1389450003349254","volume":"1","author":"Seiler N.","year":"2000","unstructured":"Seiler N.; Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Curr Drug Targets 2000,1(2),119-153","journal-title":"Curr Drug Targets"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1073\/pnas.0610832104","volume":"104","author":"Wang G.","year":"2007","unstructured":"Wang G.; Shang L.; Burgett A.W.; Harran P.G.; Wang X.; Diazonamide toxins reveal an unexpected function for ornithine delta-amino transferase in mitotic cell division. Proc Natl Acad Sci USA 2007,104(7),2068-2073","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.635581","volume":"200","author":"O\u2019Donnell J.J.","year":"1978","unstructured":"O\u2019Donnell J.J.; Sandman R.P.; Martin S.R.; Gyrate atrophy of the retina: inborn error of L-ornithin:2-oxoacid aminotransferase. Science 1978,200(4338),200-201","journal-title":"Science"},{"key":"ref=55","first-page":"174","volume":"30","author":"Shih V.E.","year":"1978","unstructured":"Shih V.E.; Berson E.L.; Mandell R.; Schmidt S.Y.; Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina. Am J Hum Genet 1978,30(2),174-179","journal-title":"Am J Hum Genet"},{"key":"ref=56","first-page":"820","volume":"39","author":"Ueda M.","year":"1998","unstructured":"Ueda M.; Masu Y.; Ando A.; Maeda H.; Del Monte M.A.; Uyama M.; Ito S.; Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1998,39(5),820-827","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/jnci\/djj395","volume":"98","author":"Tomiyama A.","year":"2006","unstructured":"Tomiyama A.; Serizawa S.; Tachibana K.; Sakurada K.; Samejima H.; Kuchino Y.; Kitanaka C.; Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. J Natl Cancer Inst 2006,98(20),1462-1473","journal-title":"J Natl Cancer Inst"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjc.2012.559","volume":"108","year":"2006","unstructured":"Shen, Y.C.; Ou, D.L.; Hsu, C.; Lin, K.L.; Chang, C.Y.; Lin, C.Y.; Liu, S.H.; Cheng, A.L. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. Br. J. Cancer, 2006,108(8),72-81"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210910100803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/196344\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210910100803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T01:41:30Z","timestamp":1659404490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/196344\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666210910100803","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}